Table 1 The characteristics of 96 NHL patients
From: Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling
No. of Patients (%) | |
|---|---|
Age, years (median, range) | 57, 23-87 |
Sex | |
Male | 61 (63.5) |
Female | 35 (36.5) |
Histologic type (WHO) | |
Diffuse large B cell lymphoma | 70 (72.9) |
Mantle cell lymphoma | 6 (6.2) |
T cell lineage | 16 (16.7) |
Follicular lymphoma | 2 (2.1) |
Burkitt's lymphoma | 2 (2.1) |
Performance status | |
0 | 32 (33.3) |
1 | 60 (62.5) |
2 | 4 (4.2) |
Stage | |
I | 16 (16.7) |
II | 40 (41.6) |
III | 18 (18.8) |
IV | 22 (22.9) |
Extra-nodal involvement | |
Absent | 43 (44.8) |
Present | 57 (55.2) |
IPI | |
Low | 52 (54.1) |
Low-intermediate | 18 (18.8) |
High-intermediate | 20 (20.8) |
High | 6 (6.3) |
Bone marrow involvement | |
Absent | 90 (93.8) |
Present | 5 (5.2) |
Not identified | 1 (1.0) |
Therapeutic regimen | |
R-CHOP | 79 (82.3) |
CHOP | 8 (8.3) |
Others | 9 (9.4) |